In conclusion, changes in SNS and PSNS activity as well as the expression of neurotrophic factors play significant roles in the pathogenesis of NAFLD and its progression to NASH and cirrhosis. The gene discussed is ARTN; the disease is metabolic dysfunction-associated steatotic liver disease.